PP-189 Evidence-Based Case Report: The Use of Statin on Slowing Progression of Mitral Stenosis Patient with Rheumatic Heart Disease

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-189 Evidence-Based Case Report: The Use of Statin on Slowing Progression of Mitral Stenosis Patient with Rheumatic Heart Disease

Objective The burden of rheumatic heart disease continues to be a major contributor morbidity and premature death in a poor and developing countries. In rheumatic heart disease, the mitral valve…

read more

PP-184 Relationship Between Vitamin 12 and Syntax Score

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-184 Relationship Between Vitamin 12 and Syntax Score

Vitamin B12 is required components in the metabolism of homocysteine (Hcy). Deficiency of vitamin B 12 has been implicated in endothelial dysfunction and cardiovascular disease via Hyperhomocysteinemia. However, the association…

read more

PP-185 The Impact of Percutaneus Transmitral Valvuloplasty on Platelet-Lymphocyte Ratio in Patients with Severe Rheumatic Mitral Stenosis

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-185 The Impact of Percutaneus Transmitral Valvuloplasty on Platelet-Lymphocyte Ratio in Patients with Severe Rheumatic Mitral Stenosis

The association between severe rheumatic mitral stenosis (SRMS) and high level of thromboembolic event are well known. Activated platelets stimulate thrombus formation in response to rupture of atherosclerotic plaques or…

read more

PP-179 Do Varying Antidiabetic Regimens Make Any Difference in Coronary Atherogenesis: A Retrospective and Observational Study

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-179 Do Varying Antidiabetic Regimens Make Any Difference in Coronary Atherogenesis: A Retrospective and Observational Study

Objective Diabetes is an independent risk factor for cardiovascular disease. The aim of this study is to examine the effects of oral antidiabetic drugs and subcutaneous insulin treatment on coronary…

read more

PP-177 Oxidative Preconditioning with Hyperbaric Oxygen Therapy Protects the Heart Against Drug Induced Cardiomyotoxicity

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-177 Oxidative Preconditioning with Hyperbaric Oxygen Therapy Protects the Heart Against Drug Induced Cardiomyotoxicity

Introduction Drugs can lead to cardiomytoxic adverse effects. Doxorubicin can an important example such these drugs. Preventive methods are also investigated for protecting cardiomyocytes in patients who need to use…

read more
Get Clinical Tree app for offline access